Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Capital Expenditures: 2018-2022

Historic Capital Expenditures for Gossamer Bio (GOSS) over the last 5 years, with Dec 2022 value amounting to $410,000.

  • Gossamer Bio's Capital Expenditures was N/A to $53,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $212,000, marking a year-over-year change of. This contributed to the annual value of $410,000 for FY2022, which is 73.48% down from last year.
  • Latest data reveals that Gossamer Bio reported Capital Expenditures of $410,000 as of FY2022, which was down 73.48% from $1.5 million recorded in FY2021.
  • Gossamer Bio's Capital Expenditures' 5-year high stood at $3.5 million during FY2018, with a 5-year trough of $410,000 in FY2022.
  • Moreover, its 3-year median value for Capital Expenditures was $1.5 million (2020), whereas its average is $1.2 million.
  • Its Capital Expenditures has fluctuated over the past 5 years, first grew by 2.86% in 2021, then slumped by 73.48% in 2022.
  • Yearly analysis of 5 years shows Gossamer Bio's Capital Expenditures stood at $3.5 million in 2018, then dropped by 15.01% to $3.0 million in 2019, then crashed by 49.33% to $1.5 million in 2020, then climbed by 2.86% to $1.5 million in 2021, then tumbled by 73.48% to $410,000 in 2022.